Optimization of decellularization methods using human small intestinal submucosa for scaffold generation in regenerative medicine

por Mineta, Shumei, Endo, Shunji, Ueno, Tomio
Publicado 2023

Simultaneous triple cancer of the esophagus, pancreas and rectum treated with multimodal strategies: a case report

por Imamura, Hiroki, Hirose, Hajime, Endo, Shunji, Hashimoto, Yasuji, Takeda, Masashi, Kidogami, Shinya, Mokutani, Yukako, Kishimoto, Tomoya, Yoshioka, Shinichi, Tamura, Shigeyuki, Sasaki, Yo
Publicado 2020

Prognostic factors for elderly gastric cancer patients who underwent gastrectomy

por Endo, Shunji, Yamatsuji, Tomoki, Fujiwara, Yoshinori, Higashida, Masaharu, Kubota, Hisako, Matsumoto, Hideo, Tanaka, Hironori, Okada, Toshimasa, Yoshimatsu, Kazuhiko, Sugimoto, Ken, Ueno, Tomio
Publicado 2022

Coexisting primary tumors from esophageal cancer and myelodysplastic syndromes: A case report

por Imamura, Hiroki, Tamura, Shigeyuki, Hattori, Hideki, Kidogami, Shinya, Mokutani, Yukako, Kishimoto, Tomoya, Hashimoto, Yasuji, Hirose, Hajime, Yoshioka, Shinichi, Kuwayama, Maki, Endo, Shunji, Sasaki, Yo
Publicado 2021

Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study

por Endo, Shunji, Terazawa, Tetsuji, Goto, Masahiro, Tanaka, Ryo, Kato, Takeshi, Fujitani, Kazumasa, Kawakami, Hisato, Sakai, Daisuke, Kurokawa, Yukinori, Tsujinaka, Toshimasa, Shimokawa, Toshio, Satoh, Taroh
Publicado 2022

Bridge to surgery using a self-expandable metallic stent for stages II–III obstructive colorectal cancer

por Ohta, Katsuya, Ikenaga, Masakazu, Ueda, Masami, Iede, Kiyotsugu, Tsuda, Yujiro, Nakashima, Shinsuke, Nojiri, Takashi, Matsuyama, Jin, Endo, Shunji, Murata, Jun, Kobayashi, Ichizo, Tsujii, Masahiko, Yamada, Terumasa
Publicado 2020

Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report

por Endo, Shunji, Fujiwara, Yoshinori, Kurose, Koji, Higashida, Masaharu, Kubota, Hisako, Okamoto, Yuko, Mineta, Shumei, Tanaka, Hironori, Okada, Toshimasa, Tsuruta, Atsushi, Akiyama, Takashi, Oga, Toru, Ueno, Tomio
Publicado 2020

Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric...

por Kawakami, Hisato, Nishikawa, Kazuhiro, Shimokawa, Toshio, Fujitani, Kazumasa, Tamura, Shigeyuki, Endo, Shunji, Kobayashi, Michiya, Kawada, Junji, Kurokawa, Yukinori, Tsuburaya, Akira, Yoshikawa, Takaki, Sakamoto, Junichi, Satoh, Taroh
Publicado 2022

Randomized, Open‐Label Phase II Study Comparing Capecitabine‐Cisplatin Every 3 Weeks with S‐1‐Cisplatin Every 5 Weeks in Chemotherapy‐Naïve Patients with HER2‐Negative Advanced Gas...

por Kawakami, Hisato, Takeno, Atsushi, Endo, Shunji, Makari, Yoichi, Kawada, Junji, Taniguchi, Hirokazu, Tamura, Shigeyuki, Sugimoto, Naotoshi, Kimura, Yutaka, Tamura, Takao, Fujitani, Kazumasa, Sakai, Daisuke, Shimokawa, Toshio, Kurokawa, Yukinori, Satoh, Taroh
Publicado 2018

Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S‐1 chemotherapy after gastrectomy: A multicenter, open‐label, single‐arm, prospective...

por Imamura, Hiroshi, Matsuyama, Jin, Nishikawa, Kazuhiro, Endo, Shunji, Kawase, Tomono, Kimura, Yutaka, Fukui, Junichi, Kawada, Junji, Kurokawa, Yukinori, Fujitani, Kazumasa, Sakai, Daisuke, Kawakami, Hisato, Tsujinaka, Toshimasa, Shimokawa, Toshio, Matsubara, Yoshihiro, Satoh, Taroh, Furukawa, Hiroshi
Publicado 2021

Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)

por Matsuyama, Jin, Terazawa, Tetsuji, Goto, Masahiro, Kawabata, Ryohei, Endo, Shunji, Imano, Motohiro, Fujita, Shoichiro, Akamaru, Yusuke, Taniguchi, Hirokazu, Tatsumi, Mitsutoshi, Lee, Sang-Woong, Kawakami, Hisato, Kurokawa, Yukinori, Shimokawa, Toshio, Sakai, Daisuke, Kato, Takeshi, Fujitani, Kazumasa, Satoh, Taroh
Publicado 2022

Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study

por Kawabata, Ryohei, Chin, Keisho, Takahari, Daisuke, Hosaka, Hisashi, Muto, Osamu, Shindo, Yoshiaki, Nagata, Naoki, Yabusaki, Hiroshi, Imamura, Hiroshi, Endo, Shunji, Kashiwada, Tomomi, Nakamura, Masato, Hihara, Jun, Kobayashi, Michiya, Sagawa, Tamotsu, Saito, Soh, Sato, Atsushi, Yamada, Takeshi, Okano, Naohiro, Shimada, Ken, Matsushima, Masashi, Kataoka, Masato, Matsumoto, Shigemi, Goto, Masahiro, Kotaka, Masahito, Shiraishi, Takeshi, Yamai, Hiromichi, Nagashima, Fumio, Ishizuka, Naoki, Yamaguchi, Kensei
Publicado 2023